Liver fibrosis is an important cause of morbidity and mortality worldwide and represent a
difficult clinical challenge of global importance. The liver fibrosis progression needs to be controlled
because persisted liver fibrosis can lead to liver cirrhosis or even hepatocellular carcinoma. Despite
significant advances in the understanding of the liver fibrosis development, the therapeutic effect of
drugs used in liver fibrosis treatment is not sufficient. Today, nanotechnology has been considered as a
potential tool for developing novel drug delivery systems for the improved imaging and various
diseases, including liver fibrosis. In this article, we discussed the use of nanotechnology for the
treatment and imaging of liver fibrosis.
Keywords: Antifibrotic therapy, antiviral therapy, hepatic stellate cells, liver fibrosis, nanotechnology, siRNA.
Rights & PermissionsPrintExport